ArticleJournal of cardiothoracic surgery2025
Three-dimensional imaging assisted segmentectomy in the treatment of localized bronchiectasis: a retrospective analysis.
Article in Journal of cardiothoracic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Surgical intervention in bronchiectasis and pulmonary tuberculosis.Breathe (Sheffield, England) · 2026Review
- Application of visualization three-dimensional medical imaging technology based on mobile platform in surgery of giant thyroid tumors: a case report.Journal of medical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSurgical treatment is crucial in managing bronchiectasis. Segmentectomy, although a complex procedure, has become more feasible with advancements in thin-slice CT and three-dimensional imaging. These technologies enhance preoperative anatomical understanding and surgical planning. This study aims to demonstrate the viability of using three-dimensional imaging assistance for treating localized bronchiectasis through segmentectomy.
methodsFrom 2021 to 2023, a total of 34 patients with bronchiectasis underwent segmentectomy. We collected and then analyzed potential factors including general conditions, preoperative clinical symptoms, surgical procedures, length of postoperative hospital stay, incidence of postoperative complications and postoperative follow-ups.
resultsOf the 34 surgical patients, 8 were men and 26 were women, resulting in a total of 34 operations. The average surgical time for segmentectomy was 157.7 ± 63.4 min. The average intraoperative blood loss was 115.9 ± 107.4 ml. Postoperative tube placement lasted an average of 6.5 ± 2.4 days, with an average drainage volume of 724.7 ± 500.9 ml. The average hospital stay was 8.2 ± 3.4 days. Among these patients, 2 developed pneumothorax and 2 experienced air leaks. Additionally, 4 patients developed pneumonia postoperatively. Over an average follow-up period of 14.3 months, most patients showed symptom improvement, with only two cases of recurrence.
conclusionsSegmentectomy has acceptable postoperative morbidity, mortality, and outcomes. Therefore, segmentectomy is a viable option for the treatment of localized bronchiectasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.